• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Traws Pharma, Inc. - Common Stock (NQ:TRAW)

0.3693 -0.0338 (-8.39%)
Delayed Quote Updated: 3:58 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 257,685
Open 0.4137
Bid (Size) 0.3747 (100)
Ask (Size) 0.3855 (1,000)
Prev. Close 0.4031
Today's Range 0.3621 - 0.4137
52wk Range 0.3621 - 3.230
Shares Outstanding 5,564,315
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights
August 14, 2026
From Traws Pharma, Inc.
Via GlobeNewswire
News headline image
Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program
June 22, 2026
Resubmission of updated data package to MHRA, expected in 3Q 2026, to enable Phase 2a human influenza Challenge study to proceed 
From Traws Pharma, Inc.
Via GlobeNewswire

Performance

52-Week Range 88.6% below 52-week high
0.3693
0.3652W Low 3.2352W High
1 Week 16.9% below 1-week high
0.361W Low 0.441W High

Traws Pharma, Inc. - Common Stock (TRAW) traded between $0.36 and $3.23 over the past 52 weeks and last traded at $0.37, 88.6% below its 52-week high. Over the past week it ranged between $0.36 and $0.44.

Past 12 Months
-11.2%
-31.0%
-39.5%
-73.4%
-72.2%
-87.1%
1W -$0.05
1M -$0.17
3M -$0.24
6M -$1.02
YTD -$0.96
1Y -$2.49

TRAW was -87.1% over the past year, -73.4% over six months, -72.2% year to date, -11.2% in the last week.

12 Months vs Market
TRAW
-87.1%
DIA
+12.4%
SPY
+14.9%
QQQ
+17.5%
IWM
+11.1%

Over the past 12 months TRAW returned -87.1% versus DIA (Dow) +12.4%, SPY (S&P 500) +14.9%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +11.1%.

Volume & Liquidity 0.44× 3-mo avg
Today 257,685 3-mo avg 579.4K
1W
143.9K
1M
1.5M
3M
579.4K
6M
1.4M
YTD
991.1K
1Y
872.0K

TRAW most recently traded 257,685 shares against a 3-month average daily volume of 579.4K.

More News

Read More
Monday's session: top gainers and losers ↗
June 15, 2026
Via Chartmill
Gapping stocks in Monday's session ↗
June 15, 2026
Via Chartmill
TRAW Stock Slides In Volatile Session –  What’s The Latest On Its Phase 2 Trial For COVID-19 Treatment? ↗
January 26, 2026
Via Stocktwits
Monday's pre-market session: top gainers and losers ↗
June 15, 2026
Via Chartmill
News headline image
Traws Pharma Provides Regulatory Update on Influenza Program
June 12, 2026
From Traws Pharma, Inc.
Via GlobeNewswire
News headline image
Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks
May 27, 2026
From Traws Pharma, Inc.
Via GlobeNewswire
News headline image
Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results
May 15, 2026
From Traws Pharma, Inc.
Via GlobeNewswire
Unusual volume stocks are being observed in Monday's session. ↗
May 11, 2026
Via Chartmill
Friday's session: top gainers and losers ↗
May 08, 2026
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
May 08, 2026
Via Chartmill
Gapping stocks in Friday's session ↗
May 08, 2026
Via Chartmill
Which stocks are moving before the opening bell on Friday? ↗
May 08, 2026
Via Chartmill
News headline image
Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections
May 08, 2026
From Traws Pharma, Inc.
Via GlobeNewswire
News headline image
TRAWS PHARMA INC (NASDAQ:TRAW) Reports 2025 Earnings Beat Amid Dilutive $60M PIPE Financing and FDA Hold ↗
April 15, 2026
Via Chartmill
Topics Earnings
News headline image
Traws Pharma Reports Full Year 2025 Results and Provides Business Highlights
April 15, 2026
From Traws Pharma, Inc.
Via GlobeNewswire
News headline image
Traws Pharma Announces Up to $60 Million Private Placement Financing
April 15, 2026
From Traws Pharma, Inc.
Via GlobeNewswire
Top stock movements in today's session. ↗
February 19, 2026
Via Chartmill
Gapping stocks in Thursday's session ↗
February 19, 2026
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
February 19, 2026
Via Chartmill
News headline image
Traws Pharma Completes Analysis of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients and Provides Updates for Additional Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza
February 19, 2026
From Traws Pharma, Inc.
Via GlobeNewswire
Top movers analysis in the middle of the day on 2026-01-28: top gainers and losers in today's session. ↗
January 28, 2026
Via Chartmill
News headline image
Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza
January 26, 2026
From Traws Pharma, Inc.
Via GlobeNewswire
News headline image
Traws Pharma Files Tivoxavir Marboxil Investigational New Drug (IND) Application for Influenza Therapy, and Provides Updated Results from the Ongoing Clinical Study of Ratutrelvir in PAXLOVID®-Eligible and Ineligible COVID-19 Patients
January 13, 2026
From Traws Pharma, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Traws Pharma, Inc. - Common Stock publicly traded?
Yes, Traws Pharma, Inc. - Common Stock is publicly traded.
What exchange does Traws Pharma, Inc. - Common Stock trade on?
Traws Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Traws Pharma, Inc. - Common Stock?
The ticker symbol for Traws Pharma, Inc. - Common Stock is TRAW on the Nasdaq Stock Market
What is the current price of Traws Pharma, Inc. - Common Stock?
The current price of Traws Pharma, Inc. - Common Stock is 0.3693
When was Traws Pharma, Inc. - Common Stock last traded?
The last trade of Traws Pharma, Inc. - Common Stock was at 10/16/26 03:58 PM ET
What is the market capitalization of Traws Pharma, Inc. - Common Stock?
The market capitalization of Traws Pharma, Inc. - Common Stock is 2.05M
How many shares of Traws Pharma, Inc. - Common Stock are outstanding?
Traws Pharma, Inc. - Common Stock has 2M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap